Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Immune checkpoint inhibitor (ICI)-based immunotherapy in triple negative breast cancer (TNBC) is achieving limited therapeutic results, requiring the development of more potent strategies. Combination of ICI with vaccination strategies would enhance antitumor immunity and response rates to ICI in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Aparicio, Belén, Repáraz, David, Ruiz, Marta, Llopiz, Diana, Silva, Leyre, Vercher, Enric, Theunissen, Patrick, Tamayo, Ibon, Smerdou, Cristian, Igea, Ana, Santisteban, Marta, Gónzalez-Deza, Cristina, Lasarte, Juan J., Hervás-Stubbs, Sandra, Sarobe, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666480/
https://www.ncbi.nlm.nih.gov/pubmed/36405725
http://dx.doi.org/10.3389/fimmu.2022.985886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666480/
https://www.ncbi.nlm.nih.gov/pubmed/36405725
http://dx.doi.org/10.3389/fimmu.2022.985886

Ejemplares similares